学会発表(国際)

  • Ohtani S, Masuda N, Im Y-H, Im S-A, Park B-W, Kim S-B, Yanagita Y, Takao S, Ohno S, Aogi K, Iwata H, Yoshidome K, Nishimura R, Lee E-S, Yokota I, Ohashi Y, Lee S-J, Toi M. Adjuvant capecitabine in breast cancer patients with pathologic residual disease after neoadjuvant chemotherapy : First safety analysis of CREATE-X (JBCRG-04). 2013 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 12, 2013. Session # P3-12-03.
  • Yokoyama T, Kunikane H, Katakami N, Yokota I, Saito Y, Shimozuma K, Ohashi Y, Eguchi K. A prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13). European Cancer Congress 2013 (ESMO38), Amsterdam, Netherlands, Sep 30, 2013. Abstract # P130.
  • Shinozaki T, Matsuyama Y, Ohashi Y. "Sensitivity analysis in randomized trials with partial compliance using generalized methods of moments applied to structural nested models" 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 28, 2013. Abstract C34.2.
  • Shinozaki T, Matsuyama Y, Ohashi Y. "Sensitivity analysis in randomized trials with partial compliance using generalized methods of moments applied to structural nested models" 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 28, 2013. Abstract C34.2.
  • Yokota I, Matsuyama Y, Ohashi Y. Extension on a landmarking model using a fractional polynomial function for dynamic prediction. 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 25-27, 2013. Abstract P136.
  • Yokota I, Matsuyama Y, Ohashi Y. Extension on a landmarking model using a fractional polynomial function for dynamic prediction. 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 25-27, 2013. Abstract P136.
  • Yoshida K, Tsuburaya A, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, Tanabe K, Takahashi N, Imamura H, Tatsumoto N, Hara A, Nishikawa K, Fukushima R, Kurita A, Kojima H, Miyashita Y, Oba K, Buyse ME, Morita S, Sakamoto J. SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer. Oral Abstract Session, Gastrointestinal (Noncolorectal) Cancer 2013 ASCO Annual Meeting.
  • Oba K, Burzykowski T. Validation of a surrogate endpoint by using the meta-analytic approach when the true endpoint is a rare binary-event. 34th Annual Conference of the International Society for Clinical Biostatistics 25 – 29 August 2013 in Munich, Germany.

TOP